Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia

• July 8, 2025

Profitable Presbyopia

Presbyopia is no longer a condition we simply accommodate; it has become a platform for a longitudinal relationship that can span decades.

• by Lisa M. Nijm, MD, JD

• January 1, 2026

• 10 min

Dual-Agent Eye Drop for Presbyopia

YUVEZZI™ approved for the treatment of presbyopia, blurry close-up vision due to aging

• April 20, 2026

• 2 min

Evaluation of Visual Performance Outcomes After Implantation of PanOptix and Symfony ZXR00 Intraocular Lenses Using the Area Under the Distance-Corrected Defocus Curve

• by Qi Guo, Yinping Yang, Jieyan Wang, Yuanjun Huang, Jilin Tan

• February 19, 2026